INC Research Adds AVOS Life Sciences to Strengthen Strategic and Regulatory Consulting Group
INC Research,
LLC. today announced that it has acquired the team and research products of AVOS Life Sciences. The new division of INC Research, now called AVOS Consulting, delivers strategic, operational and financial analysis to help life sciences companies successfully compete in an increasingly challenging global environment. AVOS will operate as an autonomous division within INC Research reporting directly to the chief executive officer, James Ogle,
“We are very pleased to welcome this esteemed group of experts to the INC Research family,” said Ogle.
AVOS offers independent perspectives on the future business environment for healthcare products and services to pharmaceutical, biotech, device and diagnostic companies. Key executives from AVOS, which includes Neil MacAllister, Keith Ruark, Kathleen Griffin, and David Ewbank, have a solid reputation for providing insights into areas such as healthcare trend assessment, business model development, capital allocation, portfolio optimization, accelerated drug development models and pricing and market access.
In addition to providing consulting expertise, members of the AVOS team will dedicate support to INC Research’s innovative Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances. This new approach to sponsor-CRO relationships is designed to drive maximum value for development programs through resource flexibility, corporate efficiency and risk mitigation.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
